Journal of Cardiac Failure
Volume 15, Issue 6 , Pages 475-481, August 2009

Changes in Intrathoracic Impedance are Associated With Subsequent Risk of Hospitalizations for Acute Decompensated Heart Failure: Clinical Utility of Implanted Device Monitoring Without a Patient Alert

  • Roy S. Small, MD

      Affiliations

    • Lancaster Heart and Stroke Foundation, Lancaster, Pennsylvania
    • Corresponding Author InformationReprint requests: Roy Small MD, The Heart Group, 217 Harrisburg Ave, Lancaster, PA 17603. Tel: (717) 397-5484; Fax: (717) 509 3882.
  • ,
  • William Wickemeyer, MD

      Affiliations

    • Iowa Heart Center, Des Moines, Iowa
  • ,
  • Robin Germany, MD

      Affiliations

    • University of Oklahoma, Oklahoma City, Oklahoma
  • ,
  • Bobbi Hoppe, MD

      Affiliations

    • North Memorial Hospital, Robbinsdale, Minnesota
  • ,
  • John Andrulli, DO

      Affiliations

    • Cooper Heart Institute, Camden, New Jersey
  • ,
  • Peter A. Brady, MD

      Affiliations

    • The Mayo Clinic, Rochester, Minnesota
  • ,
  • Melody Labeau

      Affiliations

    • Medtronic, Inc., Minneapolis, Minnesota
  • ,
  • Jodi Koehler, MS

      Affiliations

    • Medtronic, Inc., Minneapolis, Minnesota
  • ,
  • Shantanu Sarkar, PhD

      Affiliations

    • Medtronic, Inc., Minneapolis, Minnesota
  • ,
  • Douglas A. Hettrick, PhD

      Affiliations

    • Medtronic, Inc., Minneapolis, Minnesota
  • ,
  • W.H. Wilson Tang, MD

      Affiliations

    • The Cleveland Clinic, Cleveland, Ohio

Received 29 October 2008; received in revised form 30 December 2008; accepted 27 January 2009. published online 12 March 2009.

Abstract 

Background

Acute decreases in intrathoracic impedance monitoring have been shown to precede heart failure hospitalization in a limited population of heart failure patients. We evaluated the relationship between changes in intrathoracic impedance with hospitalizations associated with acute decompensated heart failure (ADHF) in patients with cardiac resynchronization therapy plus defibrillator (CRT-D) devices.

Methods and Results

The study enrolled 326 heart failure patients who had received CRT-D with impedance-monitoring capabilities (InSync Sentry, Medtronic). The date and duration of ADHF hospitalizations were retrospectively identified before device interrogation to obtain device diagnostic information. During 333 ± 96 days of device monitoring, 228 patients experienced 540 intrathoracic impedance fluid index threshold crossings events (TCE) at the nominal threshold value (60 Ω. days). During the initial 4-month evaluation period, 17 subjects experienced 22 ADHF hospitalizations. In the subsequent monitoring period (206 ± 95 days), 18 patients experienced 24 hospitalizations. The occurrence of TCEs during the monitoring period was independently correlated with the subsequent rate of ADHF hospitalization such that each TCE event during the risk stratification period was associated with a 35% increased risk for ADHF hospitalization in the remaining study period (P = .001). Poisson regression indicated that the subgroup of patients with an annual average rate of more than 3 threshold crossings per year during the monitoring period were significantly more likely to be hospitalized for ADHF than those patients with no TCE during the monitoring period (0.76 [0.20–1.325] vs. 0.14 [0.05–0.23] hospitalizations/subject/y [95%CI]; P = .02). Likewise, Kaplan-Meier analysis revealed that subsets of patients with more than 3 TCEs per year or with more than 30 days per year above threshold during the risk stratification period had significantly higher rates of ADHF hospitalization during the post risk stratification period than subjects with no TCE events, respectively.

Conclusions

In this multicenter retrospective cohort study, serial decreases in intrathoracic impedance sufficient to generate a fluid index threshold crossing as well as the net duration that the index remained above threshold during a 4-month monitoring period were associated with subsequent risk of ADHF hospitalization.

Key Words: Intrathoracic impedance, heart failure, hospitalization, implantable devices, decompensation

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 All decisions regarding this manuscript were made by a guest editor. Funded by Medtronic, Inc, Minneapolis, MN.

 Dr. Small has received speaking fees and research support from Medtronic, Inc. Dr. Germany is a consultant and has received research grants from Medtronic, Inc. Ms. Koehler and Ms. Labeau are full time employees of Medtronic, Inc. Drs. Hettrick and Sarkar are full time employees of Medtronic, Inc.

PII: S1071-9164(09)00034-7

doi:10.1016/j.cardfail.2009.01.012

Journal of Cardiac Failure
Volume 15, Issue 6 , Pages 475-481, August 2009